Kikuchi M,Nakamura M,Ishikawa K,et al.Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration[J].Ophthalmology,2007,114(9):1 722-1 727.
Cackett P,Yeo I,Cheung CM,et al.Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons[J].Ophthalmology,2011,118(5):846-852.
[4]
Sakurada Y,Yoneyama S,Imasawa M,et al.Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration[J].Retina,2013,33(4):841-845.
[5]
Nassar K,Grisanti S,Elfar E,et al.Serum cytokines as biomarkers for age-related macular degeneration[J].Graefes Arch Clin Exp Ophthalmol,2015,253(5):699-704.
[6]
Hirami Y,Tsujikawa A,Otani A,et al.Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy[J].Retina,2007,27(3):335-341.
[7]
Koh AH,Expert PCVP,Chen LJ,et al.Polypoidal choroidal vasculopathy:evidence-based guidelines for clinical diagnosis and treatment[J].Retina,2013,33(4):686-716.
[8]
Oishi A.The evidence for the treatment of polypoidal choroidal vasculopathy[J].Nippon Ganka Gakkai Zasshi,2015,119(11):781-786.
[9]
陈明霞.大肠癌蛋白标志物的筛选、验证及其表达的意义[D].济南:山东大学,2016.Chen MX.Identification,validation and clinical significance of novel protein markers in colorectal cancer using antibody arrays[D].Jinan:Shandong University,2016.
[10]
Li Y,Zeng J,Shi J,et al.A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development[J].J Proteome Res,2010,9(9):4 812-4 822.
[11]
Hu J,Leng X,Hu Y,et al.The features of inflammation factors concentrations in aqueous humor of polypoidal choroidal vasculopathy[J].PLoS One,2016,11(1):e0147346.
[12]
Zeng R,Wen F,Zhang X,et al.Serum levels of matrix metalloproteinase 2and matrix metalloproteinase 9elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration[J].Molecular Vision,2013,19:729-736.
[13]
Sakurada Y,Nakamura Y,Yoneyama S,et al.Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration[J].Ophthalmic Research,2015,53(1):2-7.
[14]
Mehaffy C,Hess A,Prenni JE,et al.Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis[J].Proteomics,2010,10(10):1 966-1 984.
[15]
Lee JE,Shin JP,Kim HW,et al.Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy:1-year results of the VAULT study[J].Graefes Arch Clin Exp Ophthalmol,2017,255(3):493-502.
